IGCS 2024
IGCS 2024 was held at Dublin, Ireland from October 16-18, 2024.
The IGCS 2024 Scientific Program Committee, co-chaired by Mansoor Mirza, MD (Denmark), and Sudha Sundar, MD (United Kingdom), developed an interdisciplinary program with workgroups representing various fields such as pathology, radiation, medical oncology, and more. The meeting encompassed a wide range of topics and perspectives, facilitating an in-depth exchange of ideas and knowledge on gynecologic oncology treatment, including surgical oncology, medical oncology, radiation oncology, pathology, nursing, palliative care, and global health.
Here are some highlights from the event:
“At IGCS2024 the global impact of the IGCS Gynaecologic oncology fellowship program was brought to the fore.
Fellows-in-training, graduated fellows, local mentors, international mentors and our supporting and hardworking program staff came together for a wonderful photo!
Thank you Susan for arranging.”
“Dr Mirza – so happy to see benefit IO in more ‘seasoned’ >=70 years patients treated without increased IO related toxicity.”
“These 3 amazing people Donal Brennan, Sharon O’Toole and Yvonne O’Meara were the driving force behind the inclusion of the patient voice IGCS2024, and for this I am truly thankful. It was an amazing experience, made all the more special with their unwavering support.”
“Very interesting insights by Marie Plante into the results of the important SHAPE trial, the role of LEEP/cone pre-hysterectomy and the controversial topic of minimally invasive surgery in the treatment of cervical cancer.”
“Honour to present IGCS2024 plenary session ENGOTov60/RAMP201 phase 2 primary results in low grade serous ovarian cancer. Phase 3 RAMP301 enrolling globally!”
“Exciting data from RAMP 201 study showing promising results with avutometinib and defactinib in patients with recurrent low grade serous ovarian cancer 31% ORR with median durationof response 31 months.”
“Thank you to Sarah Murphy for sharing the importance of loved experience of cancer The importance of fertility issues in cancer care Emphasising the importance of whole person care and sensitive, compassionate care.”
“Hear from the father of the novel uterine transposition procedure Reitan Ribeiro about updates and outcomes IGCS2024.“
“So exciting the IGCS patient summit is off to a wonderful start. The Dicey Scroggins IGCAN awards encompassed all that is so important in gynaecological oncology-Patient Advocacy”
“HPV Vaccine saves lives ‘Imagine if you had a daughter and she was diagnosed with cervical cancer and you could have protected her from it and you chose not to …’
Powerful Video by Laura Brennan
Big thanks to Ahmed Hefnawy for sharing.
Video attached to the post.”
“A landmark achievement for Nigeria on the last day of IGCS2024 saw the official signing of the MoU between the IGCS and GOSON (Gynaecological Oncology Society of Nigeria).”
“Cancer cervix prevention is still a challenge but not with IGCS.”
“IGCS 2024 Thoughtful, excellent distillation by Dr Ramez Eskander on role of IO in endometrial cancer including the unknown, encourages care in interpreting data.”
“IGCS 2024 wrapped up with a flair!
Much like this stunning piece of art taking shape in a serene corner of the coffee area at the convention center!
Vibrant memories of fun, interaction and insightful academic exchange across the globe!”
“Shannon Westin shares results of the DUO-E trial exploring durvalumab with chemotherapy followed by durvalumab with or without olaparib in pMMR.”
“THAT’S A WRAP! Thank you so much for joining us for IGCS2024!
See you next year in Cape Town for IGCS2025!”
For more information about IGCS24 visit oncodaily.com
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023